PSCA S2294008 C>T and Rs2976392 G>A Polymorphisms Contribute to Cancer Susceptibility: Evidence from Published Studies

Yong Gu,Qiang-Sheng Dai,Rui-Xi Hua,Bing Zhang,Jin-Hong Zhu,Jian-Wen Huang,Bin-Hui Xie,Shi-Qiu Xiong,Guo-Sheng Tan,He-Ping Li
DOI: https://doi.org/10.18632/genesandcancer.63
2015-01-01
Genes & Cancer
Abstract:PSCA gene plays an important role in cell adhesion, proliferation and survival. Increasing studies have focused on the association of PSCA gene rs2294008 C>T and rs2976392 G>A with cancer risk. However, the conclusions were inconsistent. Therefore, we performed a meta-analysis to elucidate whether there is a true association, or artifact. We systematically searched eligible studies from MEDLINE, EMBASE and CBM database. Odds ratios and 95% confidence intervals were used to evaluate the strength of the association. The final analysis included 32 studies consisting of 30028 cases and 38765 controls for the rs2294008 C>T polymorphism, and 14 studies with 8190 cases and 7176 controls for the rs2976392 G>A polymorphism. Consequently, the PSCA rs2294008 C>T polymorphism was significantly associated with increased overall cancer risk. Further stratifications indicated the increased risk was more pronounced for gastric (diffused type and non-gastric cardia adenocarcinoma) and bladder cancer. A similar association was observed for the rs2976392 G>A polymorphism. This meta-analysis demonstrated that both of the PSCA rs2294008 C>T and rs2976392 G>A polymorphisms are associated with increased cancer risk, especially for gastric cancer and bladder cancer. Further large-scale studies with different ethnicities and subtypes of gastric cancer are required to confirm the results from this meta-analysis.
What problem does this paper attempt to address?